Another widely used treatment for T2DM is the combination of sodium-glucose cotransporter-2 inhibitors (SGLT2i) with dipeptidyl peptidase-4 (DPP-4) inhibitors (27). Here, DPP4 is linked to type 2 diabetes mellitus.